Lipopolysaccharide (LPS) produces prostaglandins (PGs) concomitant to eliciting macrophage migration. We evaluated the role of PGs in initiating the migration of macrophages, especially focusing on PGD 2 and PGE 2 . In RAW264.7 macrophages, cyclooxygenase (COX)-2 inhibitor, CAY10404 [3-(4-methylsulphonylphenyl)-4-phenyl-5-trifluoromethylisoxazole], completely inhibited LPS-mediated migration at 4 h (early phase) but only partially inhibited the migration at 8 h (late phase), suggesting the presence of PG-dependent and -independent pathways. In the early phase, LPS up-regulated mRNA expressions of COX-2, hematopoietic PGD synthase (H-PGDS), and microsomal-PGE synthase 1, increasing PGD 2 and PGE 2 substantially. The chemoattractant receptor-homologous molecule expressed on Th2 lymphocytes (CRTH2) agonist, DK-PGD 2 (13-14-dihydro-15-keto-PGD 2 ), and the EP4 agonist, ONO-AE1-329 (16-{3-methoxymethyl}phenyl--tetranor-3,7-dithia-prostaglandin E 1 ), but not selective agonists of D prostanoid receptor, E prostanoid receptor (EP) 2, or EP3, stimulated random migration (chemokinesis). In peritoneal macrophages from CRTH2-deficient and H-PGDS-deficient mice, LPS-mediated migration was significantly inhibited at either early or late phases of the migration. Taken together, LPS stimulation of chemokinesis or chemotaxis, or both, occurs in macrophages via PGD 2 and PGE 2 in tandem arrangement; i.e., 1) LPS stimulates prostaglandin signaling, initiating early migration through the PGD 2 / CRTH2 and PGE 2 /EP4 signaling pathways; and 2) LPS leads induction of MCP-1, which contributes to later phase migration of the macrophages through the PGE 2 /EP4 pathway.
cantly inhibited at either early or late phases of the migration. The H-PGDS inhibitor, HQL-79 [4-(diphenylmethoxy)-1-[3-(1H-tetrazol-5-yl)propyl-piperidine]], partially inhibited the migration of the RAW264.7 macrophage in both phases. These results suggest the importance of the PGD 2 /CRTH2 pathway in LPSmediated migration of macrophages. In the late phase of migration, LPS up-regulated monocyte chemoattractant protein (MCP)-1 mRNA. The CC chemokine receptor (CCR2) antagonist, RS102895 [1Ј-[2-[4-(trifluoromethyl) phenyl]ethyl]-spiro[4H-3,1-benzoxazine-4,4Ј-piperidin]-2(1H)-one], inhibited LPS-mediated migration in the late phase without affecting the early phase. ONO-AE1-329, but not DK-PGD 2 , up-regulated MCP-1 mRNA. Taken together, LPS stimulation of chemokinesis or chemotaxis, or both, occurs in macrophages via PGD 2 and PGE 2 in tandem arrangement; i.e., 1) LPS stimulates prostaglandin signaling, initiating early migration through the PGD 2 / CRTH2 and PGE 2 /EP4 signaling pathways; and 2) LPS leads induction of MCP-1, which contributes to later phase migration of the macrophages through the PGE 2 /EP4 pathway.
Inflammatory events in the body are often a frontline defense against invading disease or injury. Activation of the macrophages induces inflammatory reactions, including phagocytosis, migration of macrophages, secretion of cytokines, and production of chemical mediators such as prostaglandins (PGs), nitric oxide, and reactive oxygen species. Lipopolysaccharide (LPS) potently activates macrophages via Toll-like receptor (TLR) 4 (Akira et al., 2001 ) and thus evokes production and secretion of immunoregulators (Ulevitch and Tobias, 1999) .
Cell motility is one of the characteristics of monocytes/ macrophages that enables infiltration from blood vessels and cell migration for antigens, contributing strategically to the defending inflammation process. One of the most important chemokine known to regulate the migration and infiltration of monocytes/macrophages is MCP-1. In macrophages, expression of the MCP-1 gene is stimulated by LPS (Kopydlowski et al., 1999) via nuclear factor-B-dependent mechanism through activation of the LPS/TLR4/MyD88 signaling pathway (Akira et al., 2001) , and CCR2, which is the sole receptor of MCP-1, induces its biological effects (Rollins, 1997) .
LPS stimulation of macrophages also up-regulates COX-2 expression in a time-dependent manner, resulting in the secretion of PGD 2 and PGE 2 (Hori et al., 2001; Rouzer et al., 2005) . PGs are produced from arachidonic acid, which is converted to PGH 2 via COX-1 and COX-2 activity. In turn, the common precursor PGH 2 can be converted into other PGs, including PGD 2 and PGE 2 by specific synthases. PGD 2 is formed by hematopoietic PGD synthase (H-PGDS) and lipokalin PGD synthase (L-PGDS) (Harris et al., 2002) . Biological roles of PGD 2 are effected via the activity of either of two plasma membrane G-protein coupled receptors, i.e., the D prostanoid receptor (DP) (also called DP1) (Narumiya et al., 1999 ) and a chemoattractant receptorhomologous molecule expressed on Th2 lymphocytes (CRTH2; also called DP2) (Nagata et al., 1999) . PGD 2 appears to exert a dual function during the inflammatory response, with the capacity to act either as a mediator via CRTH2 or via DP, in response to specific physiological or pathological conditions (Matsuoka et al., 2000; Hirai et al., 2001; Hammad et al., 2003; Kostenis and Ulven, 2006) . On the other hand, in macrophages, PGE 2 is mainly formed by microsomal PGE synthase-1 (mPGES-1) (Trebino et al., 2003) . PGE 2 activity is dependent on binding to one of four different G-protein coupled receptors, EP1, EP2, EP3, or EP4 (Nagata et al., 1999) , and the different biological effects of PGE 2 are induced via specific receptors (for review, see Narumiya et al., 1999) . PGD 2 has chemoattractant activity via CRTH2 in Th2 lymphocytes, eosinophils, basophiles (Gervais et al., 2001; Hirai et al., 2001) , and dendritic cells (Gosset et al., 2003) and has been implicated in modulating the migration capacity of dendritic cells (Legler et al., 2006) and monocytes (Panzer and Uguccioni, 2004 ). However, whether PGD 2 and PGE 2 signaling are capable of inducing chemokinetic (random cell motility) and/or chemotactic (directional cell motility) activity in macrophages has not been clarified.
In light of this association between LPS and the secretion of PGD 2 and PGE 2 and given that the PGs are delivered directly from macrophages at the onset of migration, we hypothesized that PGD 2 and PGE 2 play an instrumental role in the dispatching of naive macrophages or monocytes to the invaded region. Here, we studied the effects of LPS on chemokinetic and chemotactic reactions, with special reference to PGD 2 and PGE 2 signaling. Our results indicate 1) that PGD 2 /CRTH2 and PGE 2 /EP4 signaling play critical roles in the migration response induced by LPS in macrophages and 2) that activated PGE 2 /EP4 signaling up-regulates the expression of MCP-1, which we found contributes substantially to the late phase of macrophage migration mediated by LPS.
Materials and Methods
Preparation of Mice. H-PGDS-deficient (knockout) mice were generated as described (Mohri et al., 2006) . For generating CRTH2-deficient mice, embryo stem cells were prepared according to the method described by Satoh et al. (2006) . Germ line heterozygous offspring were generated by crossing male chimeras with female C57BL/6J mice. After 10 generations of backcrosses with wild-type C57BL/6J, we intercrossed the homozygous offspring to obtain CRTH2 mutants and wild-type animals. Animal care and treatment were conducted in accordance with the institutional guidelines of the University of Tokyo, and the experimental protocol was approved by the Institutional Animal Care and Use Committee at the University of Tokyo.
Preparation of RAW264.7 Cells. The RAW264.7 murine macrophage cell line (TIB-71; American Type Culture Collection, Manassas, VA) was maintained at 37°C in 5% CO 2 in 10-cm dishes with DMEM (Invitrogen, Carlsbad, CA) supplemented with antibiotics and 10% FBS. Cells in passages 5 to 8 were used in the experiments. Before the start of each experiment, the cells were incubated overnight in culture medium with 1% FBS. Then, the cells were incubated with or without LPS (1 g/ml) for 4 h before each experiment.
Preparation of Peritoneal Macrophages. To collect the peritoneal macrophages, we injected 2 ml of 10% protease peptone (BD Life Sciences, San Jose, CA) intraperitoneally into the C57BL/6J mice (Charles River Japan, Shin Yokohama, Japan) or into the CRTH2-or H-PGDS-deficient mice. After 48 h, the peritoneal cavity was washed with 5 ml of ice-cold phosphate-buffered saline, and the macrophages were collected. The macrophages were centrifuged, suspended in DMEM, then seeded on 6-cm dishes and allowed to adhere for 2 h. Floating cells were then washed out, and adherent cells were used in the experiments. The cells were incubated with or without LPS (1 g/ml) for 4 h before each experiment, as in the protocol involving the RAW264.7 cells.
Migration Assay. To determine whether the LPS-and prostanoid-mediated cell migrations were chemokinetic or whether the migrations were chemotactic, we performed a modified Boyden chamber assay (Boyden, 1962) . This assay involves the addition of test ligands either solely to the lower chamber or to both the upper and lower chambers, and chemokinetic substances attract the cells when substances are occupying both the upper and lower chambers. MCP-1 was used as a positive control in the assay because MCP-1 is a well established chemotactic substance for macrophages (Boyden, 1962; Zigmond and Hirsch, 1973; Entschladen et al., 2005) .
After FBS starvation, 5 ϫ 10 5 RAW264.7 cells were seeded in the 24-well upper chamber of a cell culture insert having an 8-m poresize membrane (BD Lifesciences, San Jose, CA) in 300 l of DMEM with 1% FBS. After attachment, 800 l of DMEM with each drug to be tested was added to the lower chamber, and the cells were incubated for 4 h. The polyethylene telephtalate membranes separating the upper and lower chambers were fixed with 4% paraformaldehyde in phosphate-buffered saline for 10 min and stained with Giemsa solution for 40 min. In four randomly selected fields, the cells that migrated to the reverse surface of the membrane were counted by light microscopy at 200ϫ magnification.
RT-PCR and Real-Time Quantitative RT-PCR. For mRNA isolation, initially the RAW264.7 cells were seeded in 12-well culture plates at a density of 1 ϫ 10 6 cells per well. Total RNA was subsequently extracted from the cells with TRIzol (Invitrogen Japan, Tokyo, Japan), then the cells were precipitated with isopropanol and suspended to a concentration of 1 g/l in RNase-free distilled water. RT-PCR was performed for evaluating the expression of DP and EP receptors. Briefly, first strand cDNA was synthesized with random 9-mer oligonucleotide primers and avian myeloblastosis virus Reverse Transcriptase XL at 30°C for 10 min, 55°C for 30 min, 99°C for 5 min, and 4°C for 5 min. PCR amplification using the "hot start" method with Taq-Gold (PerkinElmer Life and Analytical Sciences, Waltham, MA) was conducted in the presence of the oligonucleotide 494 Tajima et al.
primers listed in Table 1 . The PCR samples were denatured initially at 95°C for 10 min, amplified at 32 cycles at 94°C for 40 s, 55°C for 1 min, and 72°C for 1 min with a thermal cycler (Takara PCR Thermal Cycler MP; Takara Biomedicals, Tokyo, Japan). The PCR products in each cycle were separated electrophoretically on a 2% agarose gel containing 0.1% ethidium bromide. To avert the risk of contaminating the DNA, we performed PCR amplification by using total RNA in the absence of the reverse transcription step as a negative control. A model FAS-III ultraviolet trans-illuminator (Toyobo Engineering, Osaka, Japan) was used for visualizing the fluorescent bands. The predicted sizes of the amplified products are given in Table 1 .
Real-time quantitative RT (qRT)-PCR was performed for evaluating time-dependent changes in the expressions of COX-2, H-PGDS, L-PGDS, mPGES-1, and MCP-1 mRNA. An ABI PRISM 7000 instrument (Applied Biosystems, Foster City, CA) was used for qRT-PCR amplification and detection. qRT-PCR samples were prepared in triplicate, with each sample comprising a 25-l reaction mixture in a MicroAmp optical 96-well reaction plate sealed with an optical adhesive cover (Applied Biosystems). Each reaction well was treated with 2.5 l of template DNA, 12.5 l of platinum SYBR Green qPCR SuperMix-UDG (Invitrogen Japan), 10 pmol each of forward and reverse primers, and 500 nM carboxy-X-rhodamine reference dye. Plasmid and genomic DNA were serially diluted 10-fold, and this step was performed in triplicate for establishing the standard calibration curves, which are constructed by plotting the threshold cycle (Ct) versus the log concentration. For any unknown total DNA sample, the absolute quantity of both plasmid and genomic DNA was obtained by interpolating the Ct value from the sample against the standard calibration curves. A negative control was set up by substituting the template with ddH 2 O. Repeatedly, this resulted in a high Ct value, which was taken to be the nadir or lowest detectable range.
qRT-PCR was performed under three major cycling conditions: 50°C for 2 min, 95°C for 2 min, and then 40 cycles each at 95°C for 15 s and 60°C for 30 s. Upon completion of 40 PCR amplification cycles, a dissociation step was carried out for the melting curve analysis. The temperature was increased incrementally from 60 to 95°C for 20 min, during which period the fluorescence signal was monitored continually. As the template became denatured, the fluorescence levels dropped rapidly, resulting in a peak in the dissociation curve when the first derivative of the fluorescence signal was plotted against the temperature. The sizes of the amplified products along with the melting temperature or denaturation temperature of the specific primers (Table 1) were used in determining the amplification specificity.
Measurement of Prostaglandin Production in the Media. The amounts of PGD 2 and PGE 2 in each culture medium were determined as described by Pinzar et al. (2000) . Briefly, 1 ml of medium from each cell culture experiment was immediately frozen in liquid nitrogen and kept at Ϫ80°C. After the medium was thawed on ice, the prostaglandins were extracted in 2 ml of ethanol containing 0.25 N HCl. Reagents. Lipopolysaccharide from Escherichia coli O55:H5 was purchased from Sigma-Aldrich Japan (Tokyo, Japan), as was also RS102895. MCP-1 was purchased from R&D Systems (Minneapolis, MN). CAY10404, BW245C, DK-PGD 2 , PGE 2 , and HQL-79 were purchased from Cayman Chemical (Ann Arbor, MI). ONO-DI-004, ONO-AE1-259, ONO-AE-248, and ONO-AE1-329 were generously provided by Ono Pharmaceutical (Osaka, Japan).
Data Analysis. All data are expressed as the mean Ϯ S.E.M. The two-tailed Student's t test and one-way analysis of variance followed by the Tukey-Kramer post hoc test were used for statistical analyses. p Ͻ 0.05 was considered significant.
Results

COX-2-Derived PGs Mediate Migration in RAW264.7
Macrophage Stimulated by LPS. In the RAW264.7 macrophage cell line treated with LPS (1 g/ml), the LPS led to cell migration 3 h after the treatment, and the migration activity escalated, reaching maximum at 8 h (Fig. 1A) . Treatment with the selective COX-2 inhibitor CAY10404 (1 M) completely inhibited the migration up to 4 h after LPS treatment, and at 8 h, the migration was restricted to approximately 50% of maximal levels obtained with LPS alone (Fig. 1A) . PGD 2 and PGE 2 Affect LPS-Mediated Migration via CRTH2 and EP4 Receptors. In the RAW264.7 macrophages treated with LPS, expressions of COX-2, H-PGDS, and mPGES-1 mRNA were up-regulated 4 h after the LPS treatment, as established by RT-PCR (Fig. 1B) . L-PGDS, however, could not be detected in either the resting cells or the cells treated with LPS. In sharp contrast, PGD 2 and PGE 2 production increased markedly, as shown by enzymelinked immunosorbent assay (Fig. 1C) . In our efforts to identify which of the PGD 2 and PGE 2 receptor subtype(s) were responsible for LPS-mediated migration of the macrophages, CRTH2 mRNA was detected by RT-PCR, but DP receptor Fig. 1 . LPS-mediated migration of RAW264.7 macrophages was induced by PGD 2 /CRTH2 and PGE 2 /EP4 signaling. A, RAW264.7 macrophages were stimulated with 1 g/ml LPS in the absence or presence of 1 M CAY10404, a selective COX-2 inhibitor. B, semiquantitative RT-PCR analysis shows the LPS effect on expression of COX-2, H-PGDS, L-PGDS, and mPGES-1 mRNA in the cells treated with 1 g/ml LPS for 4 h. Representative of n ϭ 3 experiments. C, cells were treated with 1 g/ml LPS for 4 h. Columns, mean Ϯ S.E.M. (n ϭ 4). ‫,ءء‬ p Ͻ 0.01 versus control. D, CRTH2, EP2, EP3, and EP4 receptors are expressed in resting RAW264.7 macrophages. Representative of n ϭ 3 experiments. E, cells were either not treated with an agonist or treated with an agonist for 4 h. Robust migration was induced by the CRTH2 agonist DK-PGD 2 (0.01-1 M) and by the EP4 agonist ONO-AE1-329 (1 M). Columns, mean Ϯ S.E.M. (n ϭ 4). ‫ء‬ or ‫,ءء‬ p Ͻ 0.05 or p Ͻ 0.01, respectively, versus untreated cells. (Fig. 1D) . EP2, EP3, and EP4 receptors were also detected, but not the EP1 receptor (Fig. 1D) . Accordingly, we found that the selective DP receptor agonist BW245C (0.01-1 M) did not stimulate migration of the RAW264.7 macrophages. Conversely, however, the selective CRTH2 receptor agonist DK-PGD 2 (0.01-1 M) elicited a robust migration, effected in a concentration-dependent manner. Of the various PGE 2 receptor agonists we tested for their effects on migration, only the EP4 agonist ONO-AE1-329 (1 M) induced migration of the RAW264.7 macrophages (Fig. 1E) . Taken together, these results strongly suggest that PGD 2 and PGE 2 mediate macrophage migration via the CRTH2 and EP4 receptors.
To verify involvement of PGD 2 /CRTH2 signaling in the LPS-mediated migration, we conducted further experiments on peritoneal macrophages prepared from CRTH2-or H-PGDS-deficient mice or from a wild-type control, i.e., C57BL/ 6J. In the peritoneal macrophages from the wild-type mice, MCP-1 (20 ng/ml) and DK-PGD 2 (1 M) elicited migration ( Fig. 2A) , but in the peritoneal macrophages from CRTH2-deficient mice, DK-PGD 2 failed to induce any migration activity despite the fact that MCP-1 had demonstrated a migration potency comparable with that observed in the wildtype macrophages. In the CRTH2-deficient peritoneal macrophages, the migration activity mediated by LPS was dramatically inhibited at both 4 (early phase) and 8 (late phase) h of migration (Fig. 2B) . The migration mediated by LPS was inhibited in the H-PGDS-deficient peritoneal macrophages in a manner comparable with that of the macrophages derived from CRTH2-deficient mice (Fig. 2B) .
Chemokinetic and Chemotactic Activities of MCP-1, LPS, and Prostaglandins. As shown in Fig. 3 , migration of the RAW264.7 macrophages occurred when MCP-1 was added solely to the lower chamber of the well (i.e., in the presence of a concentration gradient of the ligand) but not when MCP-1 was added to both the upper and lower chambers (i.e., in the absence of a concentration gradient). This finding supports the notion that MCP-1 is a chemotactic agent without chemokinetic activity.
In the migration assay, a concentration gradient of LPS was also found to induce cell migration. Unlike MCP-1, LPS also induced cell migration in the absence of a concentration gradient. Migration elicited in the presence of a concentration gradient, however, was significantly (p Ͻ 0.01) higher than that elicited when LPS levels were uniform. These results indicate that LPS-mediated migration of macrophages involves both chemokinetic activity and chemotactic activity (Fig. 3) . In preliminary experiments, we also found jpet.aspetjournals.org that MCP-1-mediated chemotactic activity was completely blocked in the presence of the CCR2 antagonist RS102895 (10 M; n ϭ 4; data not shown). As depicted in Fig. 3 , in RAW264.7 macrophages, the CRTH2 agonist DK-PGD 2 and the EP4 agonist ONO-AE1-329 induced chemokinetic activity but not chemotactic activity.
Time-Dependent Changes in Expression of Prostaglandin Synthases and MCP-1. COX-2 inhibition by CAY10404 almost completely blocked the LPS-mediated migration at 4 h (early phase) but only partially inhibited the migration at 8 h (late phase; approximately 50% inhibition) (Fig. 1A) . This suggests that PG-dependent and -independent pathways were involved in the LPS-inducted migration of the macrophages. To clarify whether the PG-dependent changes were attributable to changes in prostanoid synthases, we used real-time RT-PCR to analyze time-dependent changes in the expressions of COX-2, H-PGDS, and mPGES-1 mRNA in RAW264.7 macrophages stimulated with LPS. The mRNA level of COX-2 began to increase at 1 h after LPS treatment, reaching plateau at 4 h (Fig. 4) . H-PGDS and mPGES-1 mRNA levels started increasing at 2 h, peaking at 6 to 8 h. The temporal patterns of these changes were in close agreement with changes in the PG-dependent component of LPSmediated migration. LPS treatment also led to up-regulation of MCP-1 mRNA, but the effect took place over a longer period than that for changes in the expressions of H-PGDS and mPGES-1 mRNA. These results give rise to the view that PGE 2 also contributes as an initiator of MCP-1 induction, which is important to the late phase of LPS-mediated macrophage migration.
Relevance of MCP-1 for the Late Phase of LPS-Mediated Migration. To clarify the involvement of MCP-1 in the late phase of the macrophage migration elicited by LPS, we evaluated the effects of a CCR2 receptor antagonist and an H-PGDS inhibitor on the LPS-mediated migration. As shown in Fig. 5A , the early phase of LPS-induced macrophage migration was reduced to approximately 50% of normal levels in the presence of the H-PGDS inhibitor HQL-79 (1 M), and the PGD 2 production normally stimulated by LPS in the RAW264.7 macrophages was completely blocked (resting, 45.8 Ϯ 4.0 ng/ml; ϩLPS, 633 Ϯ 46.4 ng/ml; HQL-79 ϩ LPS, 54.5 Ϯ 2.6 ng/ml). HQL-79 also inhibited the late phase of LPS-mediated migration (i.e., at 8 h). In contrast, RS102895 (10 M) inhibited the LPS-mediated migration only in the late phase, at 8 h (Fig. 5B) . These results suggest that MCP-1 is not involved in the early phase migration induced by LPS (i.e., migration that occurs within 4 h post-LPS treatment).
RS102895 did not inhibit DK-PGD 2 -mediated migration of the macrophages. In ONO-AE1-329-mediated migration, however, RS102895 partially but significantly inhibited the late phase of migration (Fig. 5C ), suggesting that MCP-1 was induced via PGE 2 /EP4 signaling in the RAW264.7 macrophages. In confirmation, CAY10404 (1 M) decreased LPSinduced MCP-1 expression at 8 h (Fig. 5D) . Finally, we found that ONO-AE1-329 (1 M) up-regulated the expression of MCP-1 mRNA in a time-dependent manner (Fig. 5E ).
Discussion
The results of this study support our hypothesis that both PGD 2 and PGE 2 play important roles in instigating the LPSinducted macrophage migration. One of our main findings was that PGD 2 /CRTH2 signaling and PGE 2 /EP4 signaling are working in tandem arrangement, the PGD 2 /CRTH2 signaling contributes to the early phase migration (within 4 h of LPS stimulation), and the PGE 2 /EP4 signaling contributes the late-phase migration (4 -8 h after LPS stimulation) in macrophage. As a consequence of this tandem arrangement, these two signaling pathways would enable a primal stream of recruiting macrophages in the inflammatory response.
The present analysis using the selective H-PGDS inhibitor demonstrated that LPS-mediated macrophage migration is mediated by H-PGDS-derived PGD 2 . Also, our results indicate that the CRTH2 receptor is essential for a cell motilityrelated PGD 2 receptor, confirming with the DK-PGD 2 , a selective and stable CRTH2 agonist, and the peritoneal macrophages prepared from CRTH2-deficient mice. PGD 2 stimulates migration in human blood monocytes and stimulates the maturation of monocytes derived from dendritic cells (Gosset et al., 2003) . Taken together, our results add to the evidence that CRTH2-dependent migration of cells is not restricted to Th2 cells, eosinophils, and basophiles (Nagata et al., 1999; Gervais et al., 2001; Monneret et al., 2001 ) but that CRTH2-dependent migration occurs in monocytes/macrophages as well. This raises the possibility that local production of PGD 2 contributes to monocyte/macrophage recruitment during LPS-mediated innate immunity responses.
In addition to stimulating the production of PGD 2 , LPS stimulated the production of PGE 2 in the present work, and PGE 2 production in turn enhanced the migration of the RAW264.7 macrophages. The migration enhancement was found to be brought about through activation of the EP4 receptor because the macrophages express EP4 mRNA and because ONO-AE1-329, a selective EP4 agonist, was a potent inducer of macrophage migration. In human monocytes, PGE 2 potentiates the chemotactic response to MCP-1, regulated on activation normal T cell expressed and secreted, and potentiates stromal cell-derived factor-1 by increasing the levels of Ca 2ϩ flux and inducing actin polymerization. This effect apparently occurs without the need for alteration in the expression of chemokine receptors but rather is induced through activation of EP2/EP4 receptors (Panzer and Uguccioni, 2004) . Moreover, PGE 2 is a general factor that is important for the development of a migratory phenotype of human monocyte-derived dendritic cells in response to EP2 and/or EP4 (Legler et al., 2006) . In our study, PGE 2 activated the migration of RAW264.7 macrophages in the late phase, suggesting that PGE 2 stimulates migration directly in these macrophages. Interestingly, our treatment of the RAW264.7 macrophages with an EP4 agonist resulted in up-regulation of the expression of MCP-1 mRNA in a time-dependent manner (Fig. 5E) . Aside from the EP4 receptor, in mast cells, PGE 2 has been reported to induce MCP-1 secretion via EP1 and EP3 receptors without inducing a change in expression of the MCP-1 gene (Nakayama et al., 2006) . Thus, in immunoreactive cells, PGE 2 appears to use different receptors and signaling pathways to modulate cell migration.
In the present study, LPS induced RAW264.7 macrophage migration not only via the PGD 2 /CRTH2 and PGE 2 /EP4 signaling pathways but also by a COX-2 inhibitor-resistant, PG-independent mechanism that may contribute to latephase migration (later than 4 h post-LPS stimulation). Upregulation of MCP-1 mRNA in response to LPS treatment was more delayed than the induction of PG-related enzymes (Fig. 4) , and a CCR2 antagonist inhibited migration in the late phase but did not affect the early step in the LPSmediated macrophage migration (Fig. 5B) . These results suggest that late phase of the LPS-mediated macrophage migration is, at least in part, mediated by MCP-1/CCR2 signaling. In addition, an EP4-selective agonist induced up-regulation of MCP-1 mRNA (Fig. 5E) ; conversely, a CCR2 antagonist inhibited the EP4 agonist-mediated macrophage migration (Fig. 5C ). Although the expression of MCP-1 is stimulated through the nuclear factor-B signaling pathway (Kopydlowski et al., 1999) , our results indicate that LPS-mediated MCP-1 induction acts in part via PGE 2 /EP4 signaling.
Contrary to MCP-1, which induces chemoattractant activity without eliciting chemokinetic activity, the CRTH2 agonist DK-PGD 2 and the EP4 agonist ONO-AE1-329 induced chemokinetic activity but not chemotaxis. These results are in agreement with Gervais et al. (2001) , who showed that PGD 2 induces chemokinesis via the CRTH2 receptor in eosinophils. In work by Verghese and Snyderman (1982) , LPS induced chemokinetic-type migration of macrophages, indicating that LPS is not strictly a chemotactic agent. We confirmed this finding in RAW264.7 macrophages because LPS demonstrated strong chemokinetic activity and weak chemoattractant activity in these cells. The weak chemoattractant activity may be attributed to MCP-1 because the activity occurred at or before 4 h from the LPS stimulation. Consistent with this view, the weak chemoattractant activity was completely suppressed by treatment with a CCR2 antagonist.
Given that chemotaxis may not occur independently of chemokinesis (Entschladen et al., 2005) , early phase chemokinetic activity mediated by PGD 2 /CRTH2 and PGE 2 /EP4 signaling in LPS-stimulated macrophages is likely to contribute to chemotactic activity. PGD 2 is easily converted to 9␣,11␤-PGF 2 or dehydrated to PGJ-series derivatives such as ⌬ 12 -PGJ 2 and 15-deoxy-⌬ 12,14 -PGJ 2 (Kostenis and Ulven, 2006) . Metabolites of PGD 2 have the capacity to act as partial agonists of the CRTH2 receptors. Therefore, despite the fact that the half-life of PGD 2 in blood is extremely short (1.5 min) (Kostenis and Ulven, 2006) , macrophage-derived PGD 2 or its derivatives are likely to activate CRTH2 signaling continuously, thus inducing macrophage migration by virtue of the continuous effect. PGD 2 -derived 15-deoxy-⌬ 12,14 -PGJ 2 is a natural ligand of peroxisome proliferator-activated receptor (PPAR)-␥, a family of nuclear receptors that function in ligand-activated transcription (Kliewer et al., 1995) . PPAR-␥ ligands have been associated with the control of inflammation, particularly in the modulation of proinflammatory cytokine production (Jiang et al., 1998; Ricote et al., 1998; Rossi et al., 2000; Straus et al., 2000) . Moreover, exogenously applied 15-deoxy-⌬ 12,14 -PGJ 2 has been reported to inhibit LPS-mediated production of nitric oxide, tumor necrosis factor-␣, and thromboxane B 2 via PPAR-␥ activation (Guyton et al., 2001 ). However, our data suggest that the PPAR-␥ pathway plays only a minor role in migration of RAW264.7 macrophages because migration occurred within 4 to 8 h after LPS stimulation in this cell type. To the best of our knowledge, ours is the first report that LPS, an important natural ligand that stimulates an innate immunity response via TLR4, induces migration of macrophages via the PGD 2 /CRTH2 and PGE 2 / EP4 signaling pathways. Further study is necessary to shed light on these signaling pathways in macrophages in vivo.
In conclusion, the results of the present study suggested that, in macrophages stimulated by LPS, the PGD 2 /CRTH2 and PGE 2 /EP4 signals work in tandem arrangement and play strategic roles in inducing migration of the macrophages. PGD 2 /CRTH2 signaling contributes the early phase migration (within 4 h of LPS stimulation), and PGE 2 /EP4 signaling is involved in producing the late-phase migration (4 -8 h after LPS stimulation). Furthermore, PGE 2 accelerate monocyte/macrophage migration via an MCP-1/CCR2-dependent mechanism in the late phase.
